Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Virology|March 6, 2015
Diversifying Selection Analysis Predicts Antigenic Evolution of 2009 Pandemic H1N1 Influenza A Virus in HumansAlexandra J Lee, Suman R Das, Wei Wang, et al.
The Journal of Infectious Diseases|May 16, 2018
Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk AssessmentTara M Babu, Ranawaka A P M Perera, Joseph T Wu, et al.
Microbiology Spectrum|June 15, 2023
Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal AntibodiesMichael Piepenbrink, Fatai Oladunni, Aitor Nogales, et al.
The Oncologist|January 14, 2012
Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancerYiqing Xu, Nanda Methuku, Praveena Coimbatore, et al.
The Journal of Infectious Diseases|April 4, 2015
High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza VaccineJessica L Halliley, Surender Khurana, Florian Krammer, et al.
Clinical and Vaccine Immunology : CVI|April 12, 2013
B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccinationMark Y Sangster, Jane Baer, Felix W Santiago, et al.
Mbio|February 10, 2021
Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19Ryan M Pace, Janet E Williams, Kirsi M Järvinen, et al.
Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
COVID-19 and human milk: SARS-CoV-2, antibodies, and neutralizing capacityRyan M Pace, Janet E Williams, Kirsi M Järvinen, et al.
Pageof 3